Remove barriers to clinical research for schedule 1 drugs with therapeutic potential
BMJ
.
2023 May 2:381:981.
doi: 10.1136/bmj.p981.
Authors
Leslie A King
1
,
David J Nutt
2
,
David E Nichols
3
4
Affiliations
1
Forensic Science Service, UK.
2
Centre for Psychedelic Research Division of Psychiatry, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
3
Department of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
4
Purdue University School of Pharmacy, West Lafayette, IN, USA.
PMID:
37130596
DOI:
10.1136/bmj.p981
No abstract available
Publication types
Editorial